Service delivery interventions for lipid testing and lipid-lowering therapy for primary and secondary prevention of cardiovascular disease in adults
Related Experiment Video
Updated: Sep 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Ana-Mihaela Zorger1, Annalena Muth1, Kamyar Shokraee2
1Cochrane Evidence Synthesis Unit Germany/UK, Institute of Public Health, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Objectives:
This is a protocol for a Cochrane review (intervention). The objectives are as follows: To assess the effects of service-delivery interventions for lipid testing and lipid-lowering therapies, such as point-of-care testing and non-physician-led or collaborative care programmes, for primary or secondary prevention of cardiovascular disease.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Hypertension IV: Drug Therapy and Lifestyle Modifications